Compile Data Set for Download or QSAR
Report error Found 234 Enz. Inhib. hit(s) with all data for entry = 7334
TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190078(US9175003, 274)
Affinity DataEC50:  2nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190021(US9175003, 180)
Affinity DataEC50:  3nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190017(US9175003, 176)
Affinity DataEC50:  4nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189988(US9175003, 147)
Affinity DataEC50:  5nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189989(US9175003, 148 | US9175003, 179)
Affinity DataEC50:  5nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190084(US9175003, 281)
Affinity DataEC50:  5nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190016(US9175003, 175)
Affinity DataEC50:  5nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190163(US9175003, 422)
Affinity DataEC50:  8nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190157(US9175003, 411)
Affinity DataEC50:  9nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190029(US9175003, 190)
Affinity DataEC50:  11nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190169(US9175003, 430)
Affinity DataEC50:  12nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190129(US9175003, 362)
Affinity DataEC50:  12nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190038(US9175003, 207)
Affinity DataEC50:  13nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189989(US9175003, 148 | US9175003, 179)
Affinity DataEC50:  13nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190027(US9175003, 188)
Affinity DataEC50:  14nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190082(US9175003, 279)
Affinity DataEC50:  15nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190022(US9175003, 181)
Affinity DataEC50:  16nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190043(US9175003, 216)
Affinity DataEC50:  17nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189992(US9175003, 151)
Affinity DataEC50:  18nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190050(US9175003, 230)
Affinity DataEC50:  18nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190000(US9175003, 159)
Affinity DataEC50:  19nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190125(US9175003, 357)
Affinity DataEC50:  19nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190031(US9175003, 194)
Affinity DataEC50:  20nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190041(US9175003, 211)
Affinity DataEC50:  21nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190171(US9175003, 432)
Affinity DataEC50:  21nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190007(US9175003, 166)
Affinity DataEC50:  22nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190055(US9175003, 237)
Affinity DataEC50:  22nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190167(US9175003, 428)
Affinity DataEC50:  22nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190048(US9175003, 228)
Affinity DataEC50:  22nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190090(US9175003, 297)
Affinity DataEC50:  23nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190044(US9175003, 217)
Affinity DataEC50:  24nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190156(US9175003, 410)
Affinity DataEC50:  24nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190155(US9175003, 409)
Affinity DataEC50:  24nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189990(US9175003, 149)
Affinity DataEC50:  26nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190145(US9175003, 384)
Affinity DataEC50:  26nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190023(US9175003, 182)
Affinity DataEC50:  29nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190170(US9175003, 431)
Affinity DataEC50:  31nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190028(US9175003, 189)
Affinity DataEC50:  31nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190168(US9175003, 429)
Affinity DataEC50:  32nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190098(US9175003, 312)
Affinity DataEC50:  32nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190042(US9175003, 212)
Affinity DataEC50:  34nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190147(US9175003, 387)
Affinity DataEC50:  34nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189998(US9175003, 157)
Affinity DataEC50:  34nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190133(US9175003, 371)
Affinity DataEC50:  36nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190173(US9175003, 438)
Affinity DataEC50:  37nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190137(US9175003, 376)
Affinity DataEC50:  38nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190051(US9175003, 231)
Affinity DataEC50:  39nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190105(US9175003, 325)
Affinity DataEC50:  42nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM189970(US9175003, 111)
Affinity DataEC50:  44nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Vtv Therapeutics

US Patent
LigandPNGBDBM190102(US9175003, 320)
Affinity DataEC50:  45nMAssay Description:The efficacy of GLP-1 receptor agonists was studied in a cAMP functional assay using HEK-293 Cells expressing the cloned human GLP-1 receptor. GLP-1-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

Displayed 1 to 50 (of 234 total ) | Next | Last >>
Jump to: